March 22, 2020 / 9:58 PM / 13 days ago

BRIEF-Liminal Biosciences says To Date, Have Not Had Any Material Disruptions To Ongoing Business Activities From COVID-19

March 22 (Reuters) - Liminal BioSciences Inc:

* LIMINAL BIOSCIENCES- TO DATE, HAVE NOT HAD ANY MATERIAL DISRUPTIONS TO ONGOING BUSINESS ACTIVITIES FROM COVID-19

* IT IS POSSIBLE THAT CO COULD BE SUBJECT TO DISRUPTIONS OR DELAYS AS SITUATION EVOLVES

* LIMINAL BIOSCIENCES- WHOLLY OWNED SUBSIDIARY PROMETIC BIOPRODUCTION FOCUSED ON DEVELOPMENT OF CO’S LEAD PLASMA-DERIVED PRODUCT CANDIDATE, RYPLAZIM

* LIMINAL BIOSCIENCES- EXPECT TO RESUBMIT BIOLOGICS LICENSE APPLICATION FOR RYPLAZIM WITH FDA IN FIRST HALF OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below